Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 



















Contents

   



(Top)
 


1 Opiates and opioids  





2 Stimulants  





3 Others  





4 See also  





5 Notes  





6 References  














List of Schedule V controlled substances (U.S.)







Add links
 









Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Permanent link
Page information
Cite this page
Get shortened URL
Download QR code
Wikidata item
 




Print/export  



Download as PDF
Printable version
 
















Appearance
   

 






From Wikipedia, the free encyclopedia
 


This is the list of Schedule V controlled substances in the United States as defined by the Controlled Substances Act.[1] The following findings are required for substances to be placed in this schedule:[2]

  1. The drug or other substance has a low potential for abuse relative to the drugs or other substances in schedule IV.
  2. The drug or other substance has a currently accepted medical use in treatment in the United States.
  3. Abuse of the drug or other substance may lead to limited physical dependence or psychological dependence relative to the drugs or other substances in schedule IV.

The complete list of Schedule V substances is as follows. The Administrative Controlled Substances Code Number and Federal Register citation for each substance is included.

Opiates and opioids

[edit]
ACSCN Drug
N/A Not more than 200 milligrams of codeine per 100 milliliters or per 100 grams[3][note 1]
N/A Not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams[3][note 1]
N/A Not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams[3][note 1]
N/A Not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit[3][note 1]
N/A Not more than 100 milligrams of opium per 100 milliliters or per 100 grams[3][note 1]
N/A Not more than 0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit[4]

Stimulants

[edit]
ACSCN Drug
1485 Pyrovalerone[5]

Others

[edit]
Box of 150 mg Lyrica (pregabalin) capsules from Finland
ACSCN Drug
2710 Brivaracetam ((2S)-2-[(4R)-2-oxo-4-propylpyrrolidin-1-yl] butanamide))[6]
2720 Cenobamate[7]
2779 Ezogabine[8]
2401 Ganaxolone[9]
2746 Lacosamide[10]
2790 Lasmiditan[11]
2782 Pregabalin[12]

See also

[edit]

Notes

[edit]
  1. ^ a b c d e This substance was expressly scheduled by the Controlled Substances Act on October 27, 1970. The 1974 Federal Register ruling (by Administrator John R. Bartels, Jr.) merely organized its listing in the Code of Federal Regulations.

References

[edit]
  1. ^ "21 CFR 1308.15". Code of Federal Regulations. Retrieved September 9, 2023.
  • ^ 21 U.S.C. § 812(b)(5) retrieved October 7, 2007
  • ^ a b c d e Bartels Jr., John R. (June 20, 1974). "PART 1308— SCHEDULES OF CONTROLLED SUBSTANCES: Annual Publication" (PDF). Government Publishing Office. Drug Enforcement Administration. Archived from the original (PDF) on September 6, 2023. Retrieved September 6, 2023.
  • ^ Bensinger, Peter (August 28, 1978). "Placement of Preparations Containing Difenoxin in Combination With Atropine Sulfate Into Schedules IV and V" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on March 3, 2022. Retrieved January 16, 2023.
  • ^ Lawn, John (May 4, 1988). "Placement of Propylhexedrine and Pyrovalerone into Schedule V" (PDF). Isomer Design. Drug Enforcement Administration. Archived (PDF) from the original on September 26, 2021. Retrieved January 16, 2023.
  • ^ Rosenberg, Chuck (March 9, 2017). "Schedules of Controlled Substances: Placement of Brivaracetam Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
  • ^ Shea, Timothy (August 20, 2020). "Schedules of Controlled Substances: Placement of Cenobamate in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved September 7, 2023.
  • ^ Leonhart, Michele (December 15, 2011). "Schedules of Controlled Substances: Placement of Ezogabine Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
  • ^ Milgram, Anne (November 9, 2022). "Schedules of Controlled Substances: Placement of Ganaxolone in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved September 7, 2023.
  • ^ Leonhart, Michele (May 21, 2009). "Schedules of Controlled Substances: Placement of Lacosamide into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
  • ^ Evans, D. Christopher (May 24, 2021). "Schedules of Controlled Substances: Placement of Lasmiditan in Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.
  • ^ Leonhart, Michele (July 28, 2005). "Schedules of Controlled Substances: Placement of Pregabalin Into Schedule V". Federal Register. Drug Enforcement Administration. Retrieved January 16, 2023.

  • Retrieved from "https://en.wikipedia.org/w/index.php?title=List_of_Schedule_V_controlled_substances_(U.S.)&oldid=1222491987"

    Categories: 
    Controlled Substances Act
    Drug-related lists
    Hidden categories: 
    Articles with short description
    Short description is different from Wikidata
     



    This page was last edited on 6 May 2024, at 07:27 (UTC).

    Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.



    Privacy policy

    About Wikipedia

    Disclaimers

    Contact Wikipedia

    Code of Conduct

    Developers

    Statistics

    Cookie statement

    Mobile view



    Wikimedia Foundation
    Powered by MediaWiki